Literature DB >> 8436349

The impact of genetics on the classification of renal carcinoma.

S Fleming1.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8436349     DOI： 10.1111/j.1365-2559.1993.tb00078.x

Source DB:  PubMed          Journal:  Histopathology        ISSN： 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  2 in total

1.  Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma.

Authors:  Ana M Molina; Darren R Feldman; Michelle S Ginsberg; Glenn Kroog; Satish K Tickoo; Xiaoyu Jia; Murielle Georges; Sujata Patil; Michael S Baum; Victor E Reuter; Robert J Motzer
Journal:  Invest New Drugs       Date:  2010-08-14       Impact factor: 3.850

2.  Evidence for aldosterone-dependent growth of renal cell carcinoma.

Authors:  Sharon King; Susan Bray; Sarah Galbraith; Lesley Christie; Stewart Fleming
Journal:  Int J Exp Pathol       Date:  2014-05-07       Impact factor: 1.925
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.